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Abstract
Background: Tourette Syndrome is a neuropsychiatric disorder characterized by chronic motor
and phonic tics. Affected individuals and their family members are at an increased risk for other
neuropsychiatric conditions including obsessive-compulsive disorder and attention deficit
hyperactivity disorder. While there is consistent evidence that genetic factors play a significant
etiologic role, no replicable susceptibility alleles have thus far been identified.
Description: Here we discuss a sharing resource of clinical and genetic data, the New Jersey
Center for Tourette Syndrome Sharing Repository, whose goal is to provide clinical data, DNA,
and lymphoblastoid cell lines to qualified researchers.
Conclusion: Opening access to the data and patient material to the widest possible research
community will hasten the identification of causal genetic factors and facilitate better understanding
and treatment of this often impairing disorder.
Background
Tourette Syndrome (TS) is a neurological disorder charac-
terized by chronic motor and phonic tics that make their
appearance before 18 years of age [1]. Prevalence ranges
from 1–3% and the disorder is found across many ethnic
groups around the world [2]. Males are affected 3 to 4
times more often than females, and the condition is less
often diagnosed in adults than in children, most likely
because tics often spontaneously diminish or disappear
by later adolescence [3]. Individuals with TS and their
family members frequently exhibit comorbid difficulties
such as obsessions and compulsions (including full-
blown OCD), which may reflect alternative manifesta-
tions of the genetic factors; ADHD; uneven neuropsycho-
logical profile (e.g., visual-motor integration and fine-
motor skill deficits); and vulnerability to anxiety and
depression are also common [4-8].
Family, segregation and twin studies consistently indicate
that genetic factors play a significant role in the etiology of
TS [for reviews, see [9-11]]. Although there have been
some initial positive findings [12-15], identification of
replicable susceptibility alleles has thus far remained elu-
sive. Possible explanations for non-replication include
phenotypic and locus heterogeneity, gene-environmental
interaction, population stratification, and differences in
phenotype definition or model specification [9,11,16-
19]. There is a need for large replication samples. Open
exchange of clinical data and biomaterials can foster new
and innovative research that may overcome these putative
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impediments and may encourage more investigators to
work on Tourette Syndrome [20-22]. To facilitate the clin-
ical data and DNA samples from well-characterized
Tourette Syndrome probands and their families reaching
the widest possible research community, we established a
sharing resource of clinical and genetic data, the New Jer-
sey Center for Tourette Syndrome Sharing Repository
(NJCTS Sharing Repository). The purpose of the reposi-
tory is to identify genetic factors that play a causal role in
Tourette Syndrome (TS), Chronic Motor or Vocal Tic Dis-
order, and associated disorders such as Chronic Tics (CT),
Obsessive-Compulsive disorder (OCD) and Attention
Deficit Hyperactivity Disorder (ADHD) by providing clin-
ical data, DNA, and/or lymphoblastoid cell lines to qual-
ified researchers from throughout the world. This article
describes repository's data collection procedures and clin-
ical assessments as well as how researchers can access the
data.
Construction and content
Subjects and methods
Subjects were recruited from the Tourette Syndrome Asso-
ciation of New Jersey (TSANJ) membership and from cli-
nicians in New Jersey, New York, and Connecticut. The
study was approved by the Rutgers University institutional
review board; all subjects or their legal guardians gave
informed written consent (and for minors, written assent)
to participate. Potential subjects (or their legal guardian)
were recruited by telephone. Subjects were informed that
the repository is open to qualified researchers from
around the world and that no personally identifiable
information (as defined by Health Insurance Portability
and Accountability Act) or link to identifying information
is included in repository. Consenting subjects (or their
legal guardian) completed a set of self-report question-
naires, were evaluated at the Rutgers University Tourette
Syndrome Clinic by a child psychiatrist experienced in the
diagnosis of TS and related disorders, and a DNA sample
was obtained most frequently from blood and rarely from
saliva. Probands were included if they met strict DSM-IV-
TR criteria [1] for TS or Chronic Motor or Vocal Tic Disor-
der. Probands not meeting this inclusion criterion are
excluded from the repository. Family members (first and
second degree) were also recruited if they reported having
had any tics or OCD. In addition, we attempted to recruit
first-degree relatives of the proband regardless of any tic or
psychiatric symptomatology.
Assessments
Self-report
The self-report questionnaire [23] includes sub-scales
assessing tic disorders, OCD, and ADHD. The tic disorder
sub-scale was adapted from Yale Global Tic Severity Scale
(YGTSS) [24]. For OCD, we used the Dimensional Yale-
Brown Obsessive-Compulsive scale [25]. The adult self-
report questionnaire included an ADHD symptom check-
list, whereas the parent-on-child questionnaire includes a
version of the SNAP-IV ADHD rating scale [26], with addi-
tional items concerning age of onset, impairment, setting,
and history of prior diagnosis or treatment. The self-report
also includes sections assessing medical history, relevant
medication use, birth and development, and family his-
tory. The adult and parent-on-child self-report question-
naires are available on the NJCTS repository website at:
http://tourette-repository.org/.
Clinical diagnosis
Final diagnoses were made according to strict DSM-IV-TR
criteria [1] by an experienced child psychiatrist (RK) spe-
cializing in Tourette Syndrome and were based upon
review of the self-report forms followed by direct semi-
structured interview of the subject or parent informant.
Each subject was assessed for the presence or absence of
the following conditions: TS or other tic disorders (includ-
ing chronic motor or vocal tic disorder, transient tic disor-
der, and tic disorder NOS), OCD or obsessive-compulsive
symptomatology (including subclinical OCD, obsessive-
compulsive symptoms, or obsessive-compulsive person-
ality disorder), ADHD (including combined, inattentive,
hyperactivity/impulsivity subtypes), and trichotilloma-
nia. For each condition for which symptoms were
reported, the level of diagnostic certainty was rated as
("Definite", "Probable", or "Possible") based on the com-
pleteness and unambiguity of the symptom reports, agree-
ment between informants, and extent to which diagnostic
criteria were met [27,28]. The diagnostician also rated tic
and OCD severity using the YGTSS Tic Severity Rating
scale [24] and DYBOCS Score Sheet [25]. The Summary
Rating Form, the YGTSS Tic Severity Rating scale, and DY-
BOCS Score Sheet are available for download from NJCTS
repository website.
To identify atypical TS cases or cases which occurred in
conjunction with potentially confounding conditions, the
cases were routinely "flagged" for the following: atypical
presentation (e.g. tics not appearing until late in adoles-
cence or after head trauma), psychosis, pervasive develop-
mental or a Autism spectrum disorder, other neurological
problems, congenital anomalies, or suspected genetic syn-
drome/chromosomal abnormalities. Since these poten-
tially confounding conditions (e.g., Austim spectrum)
were not the primary diagnoses of interest, no specialized
instruments were used to make these diagnoses. If, in the
course of the developmental/medical history, the subject
or parent reported other current or lifetime diagnoses,
these were briefly queried, noted, and flagged. Diagnoses
and flags were coded on the Summary Rating Form and
entered into a database.
Creation of permanent cell lines
Blood specimens collected from participating subjects are
brought to the Rutgers University Cell Repository at Rut-BMC Medical Genomics 2008, 1:58 http://www.biomedcentral.com/1755-8794/1/58
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gers University (RUCDR), where EBV-transformed lym-
phoblastic permanent cell lines are created, frozen,
thawed, and re-grown to ensure viability. DNA is extracted
from these cell lines for genetic studies.
Sample description
Study recruitment began in June, 2007 and is ongoing.
Our current goal is to collect DNA, cell lines and clinical
information from approximately 1000 persons who
either seem to have TS or are related to someone with TS.
In addition, we are currently assembling a research team
whose goal is to submit a multi-site collaboration grant to
substantially increase the sample size. For a summary of
the current data collection, see the NJCTS repository web-
site at: http://tourette-repository.org/. As of November 1st,
2008, a total of 75 (23 female and 52 male) probands
with TS or Chronic Motor or Vocal Tic Disorder have been
evaluated and provided DNA. Of these, 10 are singletons
(i.e., no other relatives included) and 65 have at least one
other relative included (i.e., denoted as pedigree families).
The 65 pedigree families comprise of 47 trios (proband
plus both biological parents) for association analyses. Of
the 65 pedigree families, 253 subjects were evaluated and
245 provided DNA. Of these, 86 subjects met criteria for
definite TS and 96 met criteria for TS or other tic disorders
at the probable or definite certainty level.
Utility and discussion
The NJCTS Sharing Repository contains clinical data,
DNA, and lymphoblastoid cell lines on singleton
probands, trios (probands plus both parents), and larger
pedigrees. All subjects, both affected and unaffected, are
evaluated by an experienced psychiatrist specializing in
Tourette Syndrome. Data collection is ongoing and sub-
mitted samples are available for distribution as soon as
they have been processed and the accompanying clinical/
demographic data entered (i.e., no embargo period). For
a summary of the current data collection, clinical assess-
ment forms, instructions for accessing the data, see the
NJCTS repository website at: http://tourette-reposi
tory.org/.
Conclusion
The NJCTS Sharing Repository provides a unique resource
for disseminating clinical data, DNA, and lymphoblastoid
cell lines to qualified researchers interested in conducting
genetic analyses on Tourette Syndrome and associated
conditions. The goal is to provide data access to the widest
possible research community to hasten the identification
of causal genetic factors and facilitate better understand-
ing and treatment of this often impairing disorder.
Availability and requirements
NJCTS Sharing Repository is devoted to the collection and
expedited distribution of biomaterials and clinical data
for the genetic analysis of Tourette Syndrome and related
disorders. Therefore, there is no embargo period between
sample submission and availability for distribution.
Anonymous data on family structure, age, sex, clinical sta-
tus, and diagnosis ("clinical data"), DNA samples, blood
plasma, and cell line cultures ("biomaterials") are distrib-
uted to qualified researchers at recognized biomedical
research facilities. Researchers may gain access to clinical
data, genetic analysis data, and biomaterials after receiv-
ing approval based on the qualifications of the investiga-
tors in conducting genetic research on complex disorders.
Once approval is given, clinical data and biomaterials are
sent after payment of a modest access fee. As of 4/1/08, we
have distributed clinical data and DNA to three independ-
ent international research groups. For more instructions
on how to obtain access to data, see the NJCTS repository
website at: http://tourette-repository.org/.
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